Macro Trends in Pharma: AI, Innovation, and the Impact on Outsourcing Strategy
At SCOPE Summit 2025, a panel discussion explored the industry’s macro trends, focusing on AI, innovation, and outsourcing strategies....
What Experts Are Saying About RWD in Clinical Trials
At the 2025 SCOPE Summit Conference, industry leaders gathered to discuss the integration of real-world data (RWD) into clinical...
Move Over Pharma: Patient-Led Organizations Advance Rare Disease Clinical Trials
At the 2025 SCOPE Summit, industry leaders and patient advocates discussed a transformative shift in the pharmaceutical industry: patient-led...
2025 SCOPE Summit: Advancing Patient-Centric Clinical Trials
The 2025 SCOPE Summit brought together industry leaders to explore patient-centric approaches in clinical trials, addressing the critical issue...
Merck on Investigator-Initiated Studies and Budgeting Practices at 2025 SCOPE Summit
The 2025 SCOPE Summit’s panel discussion on investigator-initiated studies (IIS) delved into the complexities of budgeting practices, highlighting the...
2025 SCOPE Summit: Transforming Clinical Trials with Pragmatic Trial Approaches
The 2025 SCOPE Summit brought together industry leaders to explore integrating real-world data into clinical trials, focusing on pragmatic...
How AstraZeneca and Mass General Brigham are Enhancing Clinical Trial Protocol Design
The SCOPE 2025 Summit showcased a groundbreaking partnership between Mass General Brigham (MGB), AstraZeneca, and Evinova, highlighting how these...
Preparing and Upskilling the Clinical Trial Workforce for AI Innovation
The 2025 SCOPE Summit’s fireside chat focused on how companies are preparing and upskilling their clinical trial workforce to...
Clinical Trial Budget Negotiation Discussion Sheds Light on Inefficiency
At the SCOPE Summit 2025 Conference, a panel discussion titled “Redesigning Site Contract and Clinical Trial Budget Negotiations to...
Eisai’s Innovative Bayesian Approach Accelerates Alzheimer’s Drug Approval
At the DPHARM conference, Eisai Inc. showcased their groundbreaking use of Bayesian methods to achieve accelerated approval for their...